Stryker to sell OP-1 product line to Olympus

12/6/2010 |

Olympus is set to buy Stryker's OP-1 product portfolio, which includes the OP-1 bone growth putty and OP-1 implant, for $60 million. Stryker said the deal is "aligned with strategic objectives for both companies," and it plans to spend a part of its R&D budget for the product line on other research initiatives that "offer the potential for greater shareholder returns."

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA